Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets EXMKT - Delayed Quote USD

Biostax Corp. (BTAX)

Compare
0.0100
+0.0030
+(42.86%)
At close: February 21 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
1,210.9140
1,484.8360
1,163.2360
738.1690
887.0300
Operating Income
-1,210.9140
-1,484.8360
-1,163.2360
-738.1690
-887.0300
Net Non Operating Interest Income Expense
-192.8930
-168.2510
-120.4030
-210.9190
-653.0490
Other Income Expense
--
-709.4460
-2,252.1800
4,535.1220
3,128.6960
Pretax Income
-1,510.6880
-2,362.5330
-3,535.8190
3,586.0340
1,588.6170
Net Income Common Stockholders
-1,510.8020
-2,362.6470
-3,536.0760
3,586.0340
1,588.6170
Average Dilution Earnings
--
--
--
--
142.2470
Diluted NI Available to Com Stockholders
-1,510.8020
-2,362.6470
-3,536.0760
3,586.0340
1,588.6170
Basic EPS
-0.02
-0.03
-0.10
7.43
3.44
Diluted EPS
-0.02
-0.03
-0.10
0.38
0.11
Basic Average Shares
83,681.6960
83,510.0010
36,290.3590
482.8260
461.1900
Diluted Average Shares
85,301.2920
83,510.0010
36,290.3590
9,394.1640
461.1900
Total Operating Income as Reported
-1,211.0280
-1,484.9500
-1,163.4930
-738.1690
-887.0300
Rent Expense Supplemental
--
1
57
--
--
Total Expenses
1,210.9140
1,484.8360
1,163.2360
738.1690
887.0300
Net Income from Continuing & Discontinued Operation
-1,510.8020
-2,362.6470
-3,536.0760
3,586.0340
1,588.6170
Normalized Income
-1,403.9210
-1,653.2010
1,881.2550
1,695.9120
-695.3311
Interest Expense
192.8930
168.2510
120.4030
210.9190
479.9310
Net Interest Income
-192.8930
-168.2510
-120.4030
-210.9190
-653.0490
EBIT
-1,317.7950
-2,194.2820
-3,415.4160
3,796.9530
2,068.5480
EBITDA
-1,290.2410
-2,139.9740
-3,415.4160
3,796.9530
2,069.1870
Reconciled Depreciation
27.5540
54.3080
--
--
0.6390
Net Income from Continuing Operation Net Minority Interest
-1,510.8020
-2,362.6470
-3,536.0760
3,586.0340
1,588.6170
Total Unusual Items Excluding Goodwill
-106.8810
-709.4460
-5,417.3310
1,890.1220
3,128.6960
Total Unusual Items
-106.8810
-709.4460
-5,417.3310
1,890.1220
3,128.6960
Normalized EBITDA
-1,183.3600
-1,430.5280
2,001.9150
1,906.8310
-1,059.5090
Tax Rate for Calcs
--
--
--
--
0.0003
Tax Effect of Unusual Items
--
--
--
--
844.7479
12/31/2020 - 8/20/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AIBT Aibotics Inc.
0.0900
+14.36%
 
VOR Vor Biopharma Inc.
1.3200
-3.65%
 
NKTX Nkarta, Inc.
1.9700
-3.90%
 
IMUX Immunic, Inc.
1.2000
-5.51%
 
GLYC GlycoMimetics, Inc.
0.2806
-4.85%
 
CADL Candel Therapeutics, Inc.
10.96
-5.76%
 
ABSI Absci Corporation
4.4750
-9.78%
 
ADTX Aditxt, Inc.
0.0872
-4.70%